En español
NIDA

Pregnant women in Appalachia face barriers to opioid treatment

Science Highlight

July 26, 2018

A NIDA-funded study has discovered that pregnant women in Appalachia face barriers to receiving medication-assisted treatment for opioid use disorders, from both insurers and providers. Investigators looked at the availability of methadone, an opioid agonist treatment, as well as buprenorphine, which is a partial agonist. Appalachian states have disproportionately higher rates of opioid use. The investigators provided an infographic to explain highlights of their findings, including data from a survey of opioid agonist therapy (OAT) providers.

Study:

Get this Publication

    Receive Latest Science Articles in your Email!
    You will only receive messages related to Latest Science

    Contact Press Office

    301-443-6245
    (8:30-5:30 ET)
    media@nida.nih.gov